Jónas Einarsson
Chairman bij ULTIMOVACS ASA
Oorsprong van het eerstegraads netwerk van Jónas Einarsson
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 21 | |
Radiumhospitalets Forskningsstiftelse
 Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Radiumhospitalets Forskningsstiftelse invests in companies from Nordic research institutions. It is a pre-seed investor and project developer focused on cancer. It strengthens cancer research at Rikshospitalet University Hospital, including The Norwegian Radium Hospital. It provides Oslo Cancer Cluster with the necessary infrastructure and management team, as well. The company was founded in 1986 and is headquartered in Lysaker, Norway.
11
| Foundation/Endowment | Financial Conglomerates | 11 |
Nucligen AS
1
| Private Company | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jónas Einarsson via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Oslo Cancer Cluster NCE
 Oslo Cancer Cluster NCE Miscellaneous Commercial ServicesCommercial Services Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
| STOREBRAND ASA | Savings Banks | Director/Board Member Corporate Officer/Principal | |
| PHOTOCURE ASA | Medical Specialties | Director/Board Member Director/Board Member Chairman Corporate Officer/Principal | |
| AstraZeneca AS | Corporate Officer/Principal | ||
Watrium AS
 Watrium AS Financial ConglomeratesFinance Watrium AS engages in active, long-term ownership of a global financial portfolio, industrial assets and top-tier commercial property. The company was founded in 2002 and is headquartered in Oslo, Norway. | Financial Conglomerates | Director/Board Member Chief Investment Officer | |
| University of Oslo | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| Norwegian School of Economics & Business Administration | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| Norwegian University of Science & Technology | College/University | Doctorate Degree Graduate Degree | |
| BI Norwegian Business School | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
Ernst & Young AS
 Ernst & Young AS Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young AS is a Norwegian company that provides accounting services. The private company is based in Oslo, Norway. The CEO of the company is Christin Erichsen Bøsterud. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| NYKODE THERAPEUTICS | Pharmaceuticals: Major | Founder Director/Board Member | |
Profier Gruppen AS
 Profier Gruppen AS Real Estate DevelopmentFinance Profier Gruppen AS owns and manages shares. The company was founded on August 31, 2005 and is headquartered in Asker, Norway. | Real Estate Development | Director/Board Member | |
Norges Skiforbund
 Norges Skiforbund Movies/EntertainmentConsumer Services Norges Skiforbund organizes sports teams and clubs. The firm prepares skiing activity and develops top athletes. It provides combined jumping and cross country skiing, alpine skiing, freestyle, and driving. The company was founded in 1908 and is headquartered in Oslo, Norway. | Movies/Entertainment | Director/Board Member | |
| Boehringer Ingelheim Norway KS | Chief Tech/Sci/R&D Officer | ||
Nextera AS
 Nextera AS Miscellaneous Commercial ServicesCommercial Services Nextera AS provides drug research for therapeutic interventions for autoimmune diseases, chronic infections, and cancer. It offers platform for protein engineering and evolution, such as life sciences, drug discovery, and lead optimization fields. The firm’s core competence lies within protein engineering and evolution utilizing its technology to epitope discovery and epitope validation, as well as lead-candidate generation and validation in-vitro. The company was founded by Geir Åge Løset and Inger Sandlie in 2009 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| Invitrogen Dynal AS | Corporate Officer/Principal | ||
Lovisenberg Diakonale Sykehus AS
 Lovisenberg Diakonale Sykehus AS Hospital/Nursing ManagementHealth Services Lovisenberg Diakonale Sykehus AS provides internal medical services. It offers mental health care, interdisciplinary specialized drug treatments, planned surgical activities, as well as oral medical treatments. The company was founded on December 9, 1992 and is headquartered in Oslo, Norway. | Hospital/Nursing Management | Chairman | |
Helse Sør-Øst RHF
 Helse Sør-Øst RHF Hospital/Nursing ManagementHealth Services Helse Sør-Øst RHF owns healthcare companies and hospitals. It provides specialized health services. The company was founded in 2007 and is headquartered in Hamar, Norway. | Hospital/Nursing Management | Chairman | |
Novo Nordisk Scandinavia AB
 Novo Nordisk Scandinavia AB Pharmaceuticals: MajorHealth Technology Novo Nordisk Scandinavia AB develops, manufactures and markets pharmaceutical products and services. Its products include medicine for diabetes, hemophilia, growth disorders, and hormone therapy. The company is headquartered in Malmö, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
Oslo universitetssykehus HF
 Oslo universitetssykehus HF Hospital/Nursing ManagementHealth Services Oslo universitetssykehus HF operates local hospital, acute hospitals, and regional hospital for residents and has a number of national tasks. It carries out patient treatment, research, and trial treatments, gives advice and provides education. The company was founded on December 1, 2008 and is headquartered in Oslo, Norway. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
| CIRCIO HOLDING ASA | Biotechnology | Director/Board Member Founder | |
| Vågar AS | Chairman | ||
| Vågar Eiendom AS | Chairman | ||
| Vågar Havn AS | Chairman | ||
| Farmastat AS | Chairman | ||
| Norwegian Institute of Technology | College/University | Graduate Degree | |
Ulven AS
 Ulven AS Real Estate DevelopmentFinance Ulven AS invests in real property and other companies. It offers buildings, service functions, and housing services. The company was founded on October 17, 2005 and is headquartered in Oslo, Norway. | Real Estate Development | Director/Board Member | |
| Ulvenveien 91 AS | Director/Board Member | ||
| Ulven P22-24 AS | Director/Board Member | ||
| Gilhus Invest AS | Director/Board Member | ||
Ulven P28 AS
 Ulven P28 AS Real Estate Investment TrustsFinance Ulven P28 AS provides investment services. It owns, operates, leases, and sells real estate property. The company was founded on November 24, 2005 and is headquartered in Rud, Norway. | Real Estate Investment Trusts | Director/Board Member | |
| Vågsgaten Utvikling AS | Director/Board Member | ||
| Østre Aker 16 & 24 AS | Director/Board Member | ||
| Hafjell Arena AS | Director/Board Member | ||
Curida AS
 Curida AS Pharmaceuticals: MajorHealth Technology Curida AS engages in the production of pharmaceutical products for other pharmaceutical companies, both in Norway and abroad. It manufactures and markets nasal and inhalation drug products. The company was founded in 1974 and is headquartered in Elverum, Norway. | Pharmaceuticals: Major | Director/Board Member | |
| Bristol-Myers Squibb Norway Ltd. | Chief Tech/Sci/R&D Officer | ||
Zelluna Immunotherapy AS
 Zelluna Immunotherapy AS BiotechnologyHealth Technology Zelluna Immunotherapy AS engages in research and development on biotechnology. The company is headquartered in Oslo, Norway. | Biotechnology | Director/Board Member | |
Cytovation AS
 Cytovation AS Miscellaneous Commercial ServicesCommercial Services Cytovation AS is a Norwegian clinical stage immune-oncology company that focuses on developing Cypep-1, a first-in-class immunotherapy that targets the cell membrane of tumor cells. The company is a spin-off from the University of Bergen and is headquartered in Bergen, Norway. Cypep-1 has a unique mechanism of action that eliminates cancer cells by forming pores in the plasma membrane, releasing antigens to the immune system, promoting an inflammatory microenvironment, and inducing a tumor-specific immune response by in situ vaccination. Cytovation develops treatments for solid tumors in oncology and rare diseases, building on over 15 years of cutting-edge research. The CEO is Lars Prestegarden, and the company was founded by Rolf Bjerkvig, Per Eystein, and Stein Christian Mohn. | Miscellaneous Commercial Services | Director/Board Member | |
Overvik T1 AS
 Overvik T1 AS HomebuildingConsumer Durables Overvik T1 AS develops residential and commercial properties. The private company is based in Trondheim, Norway. | Homebuilding | Chairman | |
The Johns Hopkins University (Investment Management)
 The Johns Hopkins University (Investment Management) Investment ManagersFinance The Johns Hopkins University (Investment Management) (JHU-IM) is the pension fund management arm of The Johns Hopkins University, a private research university headquartered in Baltimore, Maryland. JHU-IM invests the endowments for the university, Johns Hopkins Hospital, and other related endowed entities. | Investment Managers | Director of Investments | |
| K-TO AS | Director/Board Member | ||
| VITMED AS | Chief Executive Officer | ||
Hubro Therapeutics AS
 Hubro Therapeutics AS BiotechnologyHealth Technology Hubro Therapeutics AS develops and trades biomedical products and services. It offers a technology platform for cancer vaccines targeting stomach and colon cancer. The company was founded by Jon Amund Eriksen on November 20, 2018 and is headquartered in Oslo, Norway. | Biotechnology | Director/Board Member Chairman | |
| Blekkan Eiendom AS | Director/Board Member | ||
| Radforsk | Chief Investment Officer | ||
Artbio AS
 Artbio AS BiotechnologyHealth Technology Part of Artbio, Inc., Artbio AS is a clinical-stage radiopharmaceutical biotechnology business that works to create a new class of alpha radio ligand medicines. The private company is based in Oslo, Norway. The Norwegian company was founded in 2018. The CEO is Emanuele Ostuni. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Noorwegen | 47 |
| Denemarken | 2 |
| Nederland | 2 |
| Zweden | 2 |
| Verenigde Staten | 2 |
Sectoraal
| Health Technology | 11 |
| Finance | 8 |
| Consumer Services | 7 |
| Commercial Services | 5 |
| Health Services | 4 |
Operationeel
| Director/Board Member | 180 |
| Corporate Officer/Principal | 48 |
| Chairman | 43 |
| Chief Executive Officer | 23 |
| Independent Dir/Board Member | 18 |
Sterkste connecties
| Insiders | |
|---|---|
| Henrik Schüssler | 89 |
| Leiv Askvig | 41 |
| Bengt Håkan Englund | 18 |
| Anne Hovi Worsøe | 16 |
| Carlos de Sousa | 14 |
| Kari Grønås | 12 |
| Anders Tuv | 12 |
| Kristin Louise A. Wilhelmsen | 12 |
| Antonius Berkien | 11 |
| Øyvind Kongstun Arnesen | 10 |
| Eva S. Dugstad | 10 |
| Aitana Peire | 9 |
| Bente-Lill Romøren | 8 |
| Ketil Fjerdingen | 8 |
| Haakon Stenrod | 7 |
- Beurs
- Insiders
- Jónas Einarsson
- Bedrijfsconnecties
